Protocol for the implementation of a statewide mobile addiction program
- PMID: 36988165
- PMCID: PMC10402748
- DOI: 10.57264/cer-2022-0117
Protocol for the implementation of a statewide mobile addiction program
Abstract
With overdose deaths increasing, improving access to harm reduction and low barrier substance use disorder treatment is more important than ever. The Community Care in Reach® model uses a mobile unit to bring both harm reduction and clinical care for addiction to people experiencing barriers to office-based care. These mobile units provide many resources and services to people who use drugs, including safer consumption supplies, naloxone, medication for substance use disorder treatment, and a wide range of primary and preventative care. This protocol outlines the evaluation plan for the Community in Care® model in MA, USA. Using the RE-AIM framework, this evaluation will assess how mobile services engage new and underserved communities in addiction services and primary and preventative care.
Keywords: RE-AIM framework; addiction; buprenorphine; harm reduction; implementation; medication for addiction; mobile health; opioid use disorder; substance use disorder; syringe exchange; treatment.
Conflict of interest statement
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Figures
References
-
- Massachusetts Department of Public Health. Data brief: opioid-related overdose deaths among Massachusetts residents (2021). www.mass.gov/doc/opioid-related-overdose-deaths-among-ma-residents-novem...
-
- Baumgartner JC, Radley DC, The Commonwealth Fund. Thespike in drug overdose deaths during the COVID-19 pandemic and policy options to move forward (2021). www.commonwealthfund.org/blog/2021/spike-drug-overdose-deaths-during-cov...
-
- Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J. Addict. Med. 8(3), 153–163 (2014). - PubMed
-
- Vearrier L. The value of harm reduction for injection drug use: a clinical and public health ethics analysis. Dis. Mon. 65(5), 119–141 (2019). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical